Pathophysiology and Treatment of Clinically Resistant Cytomegalovirus Retinitis
- 1 July 1993
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 100 (7) , 1022-1031
- https://doi.org/10.1016/s0161-6420(93)31523-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992
- Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovirAntimicrobial Agents and Chemotherapy, 1991
- Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patientThe Lancet, 1991
- Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus InfectionThe Journal of Infectious Diseases, 1991
- Longitudinal Study of Cytomegalovirus Retinitis in Acquired Immune Deficiency SyndromeOphthalmology, 1990
- Foscarnet in the Treatment of Cytomegalovirus Retinitis in Acquired Immune Deficiency SyndromeOphthalmology, 1989
- Combined Short- and Long-term Therapy for the Treatment of Cytomegalovirus Retinitis Using Ganciclovir (BW B759U)Ophthalmology, 1987
- Treatment of Cytomegalovirus Retinitis with GanciclovirOphthalmology, 1987
- Monoclonal Antibody for Rapid Laboratory Detection of Cytomegalovirus Infections: Characterization and Diagnostic ApplicationMayo Clinic Proceedings, 1985
- Cytomegalovirus Retinitis in Immunosuppressed HostsAnnals of Internal Medicine, 1980